Billable/Specific ICD-10-CM Codes - Page 29

There are 35,750 ICD-10-CM codes which are billable/specific and can be used to indicate a diagnosis for reimbursement purposes as there are no codes with a greater level of specificity under each code.

  • D57.432 - Sickle-cell thalassemia beta zero with splenic sequestration
  • D57.433 - Sickle-cell thalassemia beta zero with cerebral vascular involvement
  • D57.434 - Sickle-cell thalassemia beta zero with dactylitis
  • D57.438 - Sickle-cell thalassemia beta zero with crisis with other specified complication
  • D57.439 - Sickle-cell thalassemia beta zero with crisis, unspecified
  • D57.44 - Sickle-cell thalassemia beta plus without crisis
  • D57.451 - Sickle-cell thalassemia beta plus with acute chest syndrome
  • D57.452 - Sickle-cell thalassemia beta plus with splenic sequestration
  • D57.453 - Sickle-cell thalassemia beta plus with cerebral vascular involvement
  • D57.454 - Sickle-cell thalassemia beta plus with dactylitis
  • D57.458 - Sickle-cell thalassemia beta plus with crisis with other specified complication
  • D57.459 - Sickle-cell thalassemia beta plus with crisis, unspecified
  • D57.80 - Other sickle-cell disorders without crisis
  • D57.811 - Other sickle-cell disorders with acute chest syndrome
  • D57.812 - Other sickle-cell disorders with splenic sequestration
  • D57.813 - Other sickle-cell disorders with cerebral vascular involvement
  • D57.814 - Other sickle-cell disorders with dactylitis
  • D57.818 - Other sickle-cell disorders with crisis with other specified complication
  • D57.819 - Other sickle-cell disorders with crisis, unspecified
  • D58.0 - Hereditary spherocytosis
  • D58.1 - Hereditary elliptocytosis
  • D58.2 - Other hemoglobinopathies
  • D58.8 - Other specified hereditary hemolytic anemias
  • D58.9 - Hereditary hemolytic anemia, unspecified
  • D59.0 - Drug-induced autoimmune hemolytic anemia
  • D59.10 - Autoimmune hemolytic anemia, unspecified
  • D59.11 - Warm autoimmune hemolytic anemia
  • D59.12 - Cold autoimmune hemolytic anemia
  • D59.13 - Mixed type autoimmune hemolytic anemia
  • D59.19 - Other autoimmune hemolytic anemia
  • D59.2 - Drug-induced nonautoimmune hemolytic anemia
  • D59.30 - Hemolytic-uremic syndrome, unspecified
  • D59.31 - Infection-associated hemolytic-uremic syndrome
  • D59.32 - Hereditary hemolytic-uremic syndrome
  • D59.39 - Other hemolytic-uremic syndrome
  • D59.4 - Other nonautoimmune hemolytic anemias
  • D59.5 - Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]
  • D59.6 - Hemoglobinuria due to hemolysis from other external causes
  • D59.8 - Other acquired hemolytic anemias
  • D59.9 - Acquired hemolytic anemia, unspecified
  • D60.0 - Chronic acquired pure red cell aplasia
  • D60.1 - Transient acquired pure red cell aplasia
  • D60.8 - Other acquired pure red cell aplasias
  • D60.9 - Acquired pure red cell aplasia, unspecified
  • D61.01 - Constitutional (pure) red blood cell aplasia
  • D61.02 - Shwachman-Diamond syndrome
  • D61.03 - Fanconi anemia
  • D61.09 - Other constitutional aplastic anemia
  • D61.1 - Drug-induced aplastic anemia
  • D61.2 - Aplastic anemia due to other external agents
  • D61.3 - Idiopathic aplastic anemia
  • D61.810 - Antineoplastic chemotherapy induced pancytopenia
  • D61.811 - Other drug-induced pancytopenia
  • D61.818 - Other pancytopenia
  • D61.82 - Myelophthisis
  • D61.89 - Other specified aplastic anemias and other bone marrow failure syndromes
  • D61.9 - Aplastic anemia, unspecified
  • D63.0 - Anemia in neoplastic disease
  • D63.1 - Anemia in chronic kidney disease
  • D63.8 - Anemia in other chronic diseases classified elsewhere
  • D64.0 - Hereditary sideroblastic anemia
  • D64.1 - Secondary sideroblastic anemia due to disease
  • D64.2 - Secondary sideroblastic anemia due to drugs and toxins
  • D64.3 - Other sideroblastic anemias
  • D64.4 - Congenital dyserythropoietic anemia
  • D64.81 - Anemia due to antineoplastic chemotherapy
  • D64.89 - Other specified anemias
  • D64.9 - Anemia, unspecified
  • D68.00 - Von Willebrand disease, unspecified
  • D68.01 - Von Willebrand disease, type 1
  • D68.020 - Von Willebrand disease, type 2A
  • D68.021 - Von Willebrand disease, type 2B
  • D68.022 - Von Willebrand disease, type 2M
  • D68.023 - Von Willebrand disease, type 2N
  • D68.029 - Von Willebrand disease, type 2, unspecified
  • D68.03 - Von Willebrand disease, type 3
  • D68.04 - Acquired von Willebrand disease
  • D68.09 - Other von Willebrand disease
  • D68.1 - Hereditary factor XI deficiency
  • D68.2 - Hereditary deficiency of other clotting factors
  • D68.311 - Acquired hemophilia
  • D68.312 - Antiphospholipid antibody with hemorrhagic disorder
  • D68.318 - Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
  • D68.32 - Hemorrhagic disorder due to extrinsic circulating anticoagulants
  • D68.4 - Acquired coagulation factor deficiency
  • D68.51 - Activated protein C resistance
  • D68.52 - Prothrombin gene mutation
  • D68.59 - Other primary thrombophilia
  • D68.61 - Antiphospholipid syndrome
  • D68.62 - Lupus anticoagulant syndrome
  • D68.69 - Other thrombophilia
  • D68.8 - Other specified coagulation defects
  • D68.9 - Coagulation defect, unspecified
  • D69.0 - Allergic purpura
  • D69.1 - Qualitative platelet defects
  • D69.2 - Other nonthrombocytopenic purpura
  • D69.3 - Immune thrombocytopenic purpura
  • D69.41 - Evans syndrome
  • D69.42 - Congenital and hereditary thrombocytopenia purpura
  • D69.49 - Other primary thrombocytopenia